- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06259461
Machine Learning to Construct an Association Model for Lung Cancer and Environmental Hormone
February 5, 2024 updated by: Pei-Hung Liao
Identifying the Risk of Lung Cancer Linked to Environmental Hormones
To apply machine learning to construct an association model regarding lung cancer and environmental hormones to more comprehensively identify factors that may lead to lung cancer and to improve existing lung cancer nursing assessments.
Study Overview
Status
Active, not recruiting
Conditions
Detailed Description
The present study is exploratory, and its design was divided into three stages: Stage 1 explored the environmental hormonal risk factors for lung cancer and constructed an association model using machine learning algorithms.
Stage 2 validated the results of the association model with better predictive results in clinical settings.
Stage 3 involved recommendations for reconstructing nursing assessments based on the results of the clinical model validation.
The three stages are summarized as follows.
Study Type
Observational
Enrollment (Estimated)
128
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan
- National Taipei University of Nursing and Health Science
-
Taipei, Taiwan
- National Taiwan University, Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
The study focused on lung cancer cases and investigated the association with exposure to environmental hormones
Description
Inclusion Criteria:
- 20 years or older;
- conscious, without mental disorders;
- able to use Mandarin to communicate, had a smartphone or tablet computer and could operate it by themselves,
- and were willing to participate in the study after the reasons for participation were explained and a consent form was signed, indicating their consent.
Exclusion Criteria:
- The exclusion criteria were those who could not understand the content of the nursing assessment questions and those with mental disorders.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
identify factors that may lead to lung cancer and environmental hormones.
Time Frame: the database research samples from May 2014 to December 2020.
|
This association model can assist in identifying the risk groups of lung cancer and advising physicians on the appropriate environmental hormone testing and treatment to provide nursing guidance and medical advice
|
the database research samples from May 2014 to December 2020.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2023
Primary Completion (Estimated)
June 30, 2024
Study Completion (Estimated)
June 30, 2024
Study Registration Dates
First Submitted
January 20, 2024
First Submitted That Met QC Criteria
February 5, 2024
First Posted (Estimated)
February 14, 2024
Study Record Updates
Last Update Posted (Estimated)
February 14, 2024
Last Update Submitted That Met QC Criteria
February 5, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202204055RINA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Neoplasms
-
Vergent Bioscience, Inc.RecruitingLung Cancer | Lung MetastasesUnited States, Australia
-
UNC Lineberger Comprehensive Cancer CenterSivan Innovation Ltd.CompletedLung Cancer | Neoplasms, Lung | Pulmonary Neoplasms | Neoplasms, Pulmonary | Pulmonary Cancer | Cancer of LungUnited States
-
University of UtahUnited States Department of DefenseNot yet recruitingLung Cancer | Lung NoduleUnited States
-
The First Affiliated Hospital of Guangzhou Medical...RecruitingLung Cancer | Lung | Metabolomics | Lung Cancer (NSCLC)China
-
Mayo ClinicMedtronic - MITGTerminatedLung Neoplasms | Lung Cancer | Neoplasms, Lung | Pulmonary Neoplasms | Neoplasms, Pulmonary | Pulmonary Cancer | Cancer of Lung | Cancer of the Lung | Metastatic Cancer to the LungUnited States
-
Ambu A/SOdense University HospitalCompletedLung Diseases | Lung Neoplasms | Lung Diseases, Obstructive | Lung Cancer | Lung TransplantationDenmark
-
The University of Hong KongThe Hong Kong Jockey Club Charities TrustNot yet recruitingLung Cancer | Lung Cancer ScreeningHong Kong
-
Guang'anmen Hospital of China Academy of Chinese...Recruiting
-
Everest Detection, Inc.Recruiting
-
Region StockholmUppsala University HospitalRecruiting